Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6.6Revenue $M31.9Net Margin (%)--Altman Z-Score-2.8
Enterprise Value $M-2.8EPS $-3.2Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book0.210-y EBITDA Growth Rate %--Quick Ratio13.4Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio13.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-30.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-34.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M3.9ROIC % (ttm)-81.0Gross Margin Increase y-yN

Gurus Latest Trades with BLRX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BLRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BLRX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BLRX:

    News about BLRX:

    Articles On GuruFocus.com
    Analysts Positive on BioLineRx Ltd. Following Ph2 Testing Expansion for AML May 05 2015 
    Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 

    More From Other Websites
    BioLineRx to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York Sep 03 2015
    BioLineRx to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York Sep 03 2015
    BioLineRx Reports Second Quarter 2015 Financial Results Aug 20 2015
    BioLineRx Reports Second Quarter 2015 Financial Results Aug 20 2015
    BioLineRx Up on Phase IIb Study Initiation on Leukemia Drug Aug 18 2015
    BioLineRx Announces Initiation of Phase 2b Trial for Novel AML Consolidation Treatment Aug 17 2015
    BioLineRx Announces Initiation of Phase 2b Trial for Novel AML Consolidation Treatment Aug 17 2015
    BioLineRx to Report Second Quarter 2015 Results on August 20, 2015 Aug 13 2015
    BioLineRx to Report Second Quarter 2015 Results on August 20, 2015 Aug 13 2015
    Bellerophon shares plummet after heart drug fails in study Jul 27 2015
    BioLineRx (BLRX) Stock Down on Negative Heart Disease Treatment Results Jul 27 2015
    BioLineRx Announces Top-Line Results from Bellerophon’s PRESERVATION I Clinical Trial for... Jul 27 2015
    BioLineRx Announces Top-Line Results from Bellerophon’s PRESERVATION I Clinical Trial for... Jul 27 2015
    Bioline RX Ltd (BLRX) Up Again; Broadfin, Rima Senvest Love The Stock Jun 26 2015
    BioLineRx (BLRX) Shows Strength: Stock Rises 7.4% - Tale of the Tape Jun 24 2015
    Bioline RX (BLRX) Stock Gains on Positive Test Results, Coverage Initiation Jun 22 2015
    JP Morgan: BioLineRx Will Outperform, Is Worth $5/Share On 'Promising Technology' Jun 22 2015
    Coverage initiated on BioLineRx by JMP Securities Jun 22 2015
    BioLineRx to Present Successful Results of Phase 1/2 Study for Novel Celiac Treatment at... Jun 17 2015
    BioLineRx to Present Successful Results of Phase 1/2 Study for Novel Celiac Treatment at... Jun 17 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK